Immediate Impact
46 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Works of Toraji Amano being referenced
A phase II study of trastuzumab monotherapy in pretreated patients with non-small cell lung cancers (NSCLCs) harboring HER2 alterations: HOT1303-B trial
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Toraji Amano | 158 | 146 | 136 | 29 | 387 | |
| Takanori Sano | 183 | 128 | 174 | 35 | 449 | |
| Nuriye Özdemir | 194 | 108 | 74 | 42 | 421 | |
| Silvia Catanese | 226 | 98 | 91 | 28 | 362 | |
| Salvatore Corallo | 219 | 116 | 111 | 34 | 403 | |
| Stjepko Pleština | 110 | 83 | 90 | 55 | 352 | |
| Muhammad Talal Sarmini | 162 | 94 | 101 | 28 | 433 | |
| Oktay Bozkurt | 243 | 112 | 55 | 43 | 414 | |
| Isabella Chiappino | 129 | 140 | 194 | 22 | 440 | |
| Ping‐Tsung Chen | 192 | 118 | 116 | 33 | 413 | |
| Mengjie Jiang | 124 | 88 | 99 | 33 | 366 |
All Works
Login with ORCID to disown or claim papers
Loading papers...